GOVERNMENT

Merck and Ingenuity announced today the license and deployment of the Ingenuity Pathways Analysis application for use by Merck scientists worldwide. Under the terms of the multi-year agreement, Merck scientists will utilize Ingenuity's software and extensive knowledgebase of biological networks and pathways curated from public literature. The Ingenuity Pathways Analysis application will be used in synergy with Merck's advanced Molecular Profiling tools, technologies and databases. "We are pleased to be working with Ingenuity," said Dr. Alan Sachs, vice president, Molecular Profiling, Merck Research Laboratories, and Site Head of Rosetta Inpharmatics, a wholly owned subsidiary of Merck. "Ingenuity's application software and knowledgebase will provide Merck scientists with direct access to public and proprietary biological network data, and fits well with our overall mission of providing our scientists with the best information and tools to empower cutting edge pharmaceutical research." "Ingenuity Pathways Analysis has potential for improving R&D productivity and we are excited about the opportunity to work with Merck for the broad deployment of Ingenuity Pathways Analysis which supports our mutual goal of building and deploying a world class pathways capability for Merck scientists," said Jake Leschly, chief executive officer of Ingenuity Systems. Ingenuity Pathways Analysis also will be integrated with Merck's bioinformatics systems so that scientists may seamlessly traverse these applications, simplifying workflow and streamlining genomic and proteomic analysis. Background: Ingenuity Systems is helping life science researchers understand biological systems that are foundational to human health and disease. Ingenuity delivers systems biology expertise to biologists and bioinformaticians through pathways analysis software, genome-scale computable network databases, and knowledge management services and infrastructure, resulting in increased productivity and faster drugs to market. The company was founded in 1998 and is headquartered in Mountain View, California. For more information, visit us at www.Ingenuity.com. Merck is a leading research-driven pharmaceutical company. Merck discovers, develops, manufactures and markets a broad range of innovative products to improve human and animal health, directly and through its joint ventures.